Boston Scientific (BSX) closed the most recent trading day at $99.22, moving +0.32% from the previous trading session. This move outpaced the S&P 500's daily loss of 1.07%. Meanwhile, the Dow lost ...

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX stock.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Boston Metal, a supplier of steel decarbonization technology, has successfully commissioned its multi-inert anode Molten ...

Boston Scientific’s stock surged 40.6% in the past year, far outpacing the broader market. This growth stems from strong ...

The stock's fall snapped a two-day winning streak.

Lila Sciences has secured $200 million in seed funding from Flagship Pioneering, which incubated the company, and General ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Now operational at the company’s facility in Woburn, Massachusetts, the multi-inert anode industrial cell provides the validation of the scalability of MOE Steel to achieve commercial production. The ...